STAMBP and Guillain-Barre syndrome: α-MSH, which cannot signal through MC2R expressed in the adrenals, inhibits the development of EAE [81,82] and EAN [83], a peripheral neuropathy, that serves as a model for some variants of Guillain-Barre Syndrome (GBS).